Treatment and prevention of neuropathology associated with neurodegenerative diseases
US12337018B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2024 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Apr 11, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Administering a live, attenuated Bordetella pertussis-based vaccine to a subject at risk for developing a neurodegenerative disease featuring Aβ brain plaques can prevent or reduce the amount of Aβ brain plaques that would have developed in the subject without such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.